Paid Clinical Trials Quebec
Discover 1,335 paid clinical trials in Quebec. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Observational StudyPancreatic Cancer Early Detection Consortium
Sponsor:
Arbor Research Collaborative for Health
Location:
Code:
NCT04970056
Conditions
Pancreas Cancer
Pancreas Cyst
Pancreatic Ductal Adenocarcinoma
Genetic Predisposition
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Accepted
BMS-986340, Nivolumab, DocetaxelA Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid Tumors
Sponsor:
Bristol-Myers Squibb
Location:
Code:
NCT04895709
Conditions
Cervical Cancer
Gastric/Gastroesophageal Junction Adenocarcinoma
Microsatellite Stable Colorectal Cancer
Non-Small-Cell Lung Cancer
Squamous Cell Carcinoma of Head and Neck
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
BMS-986340
BMS-936558-01
Docetaxel
BMS-986365 vs. Investigator's ChoiceA Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer
Sponsor:
Celgene
Location:
Code:
NCT06764485
Conditions
Metastatic Castration-resistant Prostate Cancer
Eligibility Criteria
Sex: Male
Age: 18+
Healthy Volunteers: Not accepted
Interventions
BMS-986365
Enzalutamide
Abiraterone
Docetaxel
Predinsone/Prednisolone
LymfitLymfit to Improve the Fitness and Quality of Life in Lymphoma Survivors
Sponsor:
McGill University
Location:
Code:
NCT05257785
Conditions
Lymphoma
Cancer Survivors
Eligibility Criteria
Sex: All
Age: 18 - 39
Healthy Volunteers: Not accepted
Interventions
Lymfit exercise intervention
Waitlist control
Interested in new trials?
Get alerts for new trials in your area by subscribing now
CanagliflozinSafety and Efficacy of Canagliflozin in Advanced CKD
Sponsor:
McGill University Health Centre/Research Institute of the McGill University Health Centre
Location:
Code:
NCT05309785
Conditions
ESRD
CKD Stage 4
CKD Stage 5
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Invokana 300 mg and 100 mg tablet
Observational StudyEarly-life MRI Biomarkers of Longer-term Respiratory Morbidity in Infants Born Extremely Preterm (EMBLEM)
Sponsor:
Children's Hospital of Eastern Ontario
Location:
Code:
NCT06065215
Conditions
Lung Function
BPD - Bronchopulmonary Dysplasia
Eligibility Criteria
Sex: All
Age: 35 - 21
Healthy Volunteers: Not accepted
Interventions
Magnetic Resonance Imaging (MRI)
Echocardiogram
Lung ultrasound
FreeO2Using a Closed-loop System for Oxygen Delivery (FreeO2) to Optimize Oxygentherapy in Patients With COPD Exacerbation
Sponsor:
Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec
Location:
Code:
NCT01393015
Conditions
COPD Exacerbation
Eligibility Criteria
Sex: All
Age: 40+
Healthy Volunteers: Not accepted
Interventions
Automated settings on the oxygen delivery device
Manual settings with FreeO2 system in collection mode
Observational StudyImproving Performance in Pediatric Trauma by Teaching Nontechnical Skills
Sponsor:
McGill University Health Centre/Research Institute of the McGill University Health Centre
Location:
Code:
NCT05910515
Conditions
Injuries
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Accepted
Interventions
Debriefing
IDE196 & CrizotinibIDE196 (Darovasertib) in Combination with Crizotinib As First-line Therapy in Metastatic Uveal Melanoma
Sponsor:
IDEAYA Biosciences
Location:
Code:
NCT05987332
Conditions
Metastatic Uveal Melanoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
IDE196
Crizotinib
Pembrolizumab
Ipilimumab
Nivolumab